Vimarsana
Biggest News Aggregation in the World

Sapu Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sapu Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sapu Bioscience Today - Breaking & Trending Today

With Cancer Immunotherapy Market Set To Grow At Double-Digit CAGR Till 2032, This Company Plans To Ride The Wave Through Treatments For Complex Cancers - Merck & Co (NYSE:MRK), Oncotelic Therapeutics (OTC:OTLC) - Vimarsana News

With Cancer Immunotherapy Market Set To Grow At Double-Digit CAGR Till 2032, This Company Plans To Ride The Wave Through Treatments For Complex Cancers - Merck & Co (NYSE:MRK), Oncotelic Therapeutics (OTC:OTLC)

Published: September 25, 2023

Oncotelic Therapeutics Inc. (OTCQB: OTLC) is a clinical-stage biopharmaceutical company.

Source: benzinga.com
Related Topics:
Oncotelic TherapeuticsincMerck CoSapu BioscienceNational Cancer Institute On UnsplashCromos PharmaNational Cancer Institute
Sapu BioScience and Cromos Pharma initiating P201 – A - Vimarsana News

Sapu BioScience and Cromos Pharma initiating P201 – A

Published: August 23, 2023

AGOURA HILLS, Calif., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the "Company" or "We" or “Our”), announced...

Source: globenewswire.com
Related Topics:
Czech RepublicUnited StatesSlovak RepublicCromos PharmaVuong TrieuPointr Data IncOxigene IncSapu BioscienceCompany Or We OurCompany Annual Report On FormMateon Therapeutics IncOncotelic Therapeutics IncRandomized PhaseAntisense OligonucleotideMetastatic PancreaticVlad BoginGlobal PharmaEastern EuropeMateon TherapeuticsNew YorkOncotelic TherapeuticsDiffuse Intrinsic Pontine GliomaAcute Myeloid LeukemiaPointr DataParkinson Disease
Sapu BioScience and Cromos Pharma initiating P201 – A Registrational trial for OT-101 in Pancreatic Cancer - Vimarsana News

Sapu BioScience and Cromos Pharma initiating P201 – A Registrational trial for OT-101 in Pancreatic Cancer

Published: August 23, 2023

AGOURA HILLS, Calif., Aug. 23, 2023 -- Oncotelic Therapeutics, Inc , announced today its joint venture partner, GMP Biotechnology Limited’s wholly owned subsidiary – Sapu Bioscience, LLC ,...

Source: marketscreener.com
Related Topics:
United StatesCzech RepublicSlovak RepublicVuong TrieuCromos PharmaCompany Annual Report On FormGlobenewswire IncMateon Therapeutics IncPointr Data IncOncotelic Therapeutics IncCompany Or We OurOxigene IncSapu BioscienceRandomized PhaseAntisense OligonucleotideMetastatic PancreaticGlobal PharmaNew YorkDiffuse Intrinsic Pontine GliomaAcute Myeloid LeukemiaParkinson DiseaseAnnual ReportCautionary NotePrivate Securities Litigation Reform Act